Rep profile
Rep profile
Cathy Cutler
company
Muro Pharmaceutical Inc., an ASTA Medica Co.
Title
Professional Medical Representative
current home
Long Beach, CA
Territory: North Orange County and eastern Los Angeles.
Customers: Allergists, pulmonologists, primary care physicians and pediatricians.
Awards: National salesperson of the year, 1995; western region salesperson of the year, 1996; Impact award, 1994; and the president's club four periods in a row.
Sales techniques: "I individualize my selling techniques for each physician in order to adapt to the different office environments. I am enthusiastic about my products and always plan for the call by preparing a selling strategy aimed at that physician."
The five P's: "'Proper preparation prevents poor performance.' My mentor trained me with this rule and I follow it for every call. I believe in working smart and always prepare for each office visit."
On goals: "I write down all my short-term and long-term goals and the steps I need to take to achieve these goals. I consistently analyze and re-evaluate the goals I set for each call. One goal is to close every call. I want the physicians to prescribe my product, not just give samples of my product."
On style: "I build friendships with the office staff and want the physicians to look forward to my visit. I always have a positive attitude when I visit the offices. Sometimes I bring in funny cartoons about the medical industry or baked goods. This is a great way for the physician to remember me and my product(s)."
The top three qualities a rep needs to succeed: "Have a competitive drive and perseverance, be enthusiastic and maintain a strong work ethic."
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.